1. Role of anti-aromatase agents in postmenopausal advanced breast cancer

   • Robin Murray

   Original Article Pages: 259 - 265

2. A phase II study of Caelyx, liposomal doxorubicin: lack of activity in patients with advanced gastric cancer

   • Anne L. Thomas
   • Ken O'Byrne
   • William P. Steward

   Original Article Pages: 266 - 268

3. Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors

   • Elisabeth I. Heath
   • Seamus O'Reilly
   • Louise B. Grochow

   Original Article Pages: 269 - 274

4. Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors

   • Katherine E. Warren
   • Mahendra C. Patel
   • Frank M. Balis

   Original Article Pages: 275 - 282

5. Combined effects of docetaxel and fluoropyrimidines on tumor growth and expression of interleukin-6 and thymidine phosphorylase in breast cancer xenografts

   • Shigeru Yamamoto
   • Junichi Kurebayashi
   • Hiroshi Sonoo

   Original Article Pages: 283 - 288

6. Maturation of dendritic cells from ovarian cancer patients

   • Eva Zavadova
   • Cherylyn A. Savary
   • Ralph S. Freedman

   Original Article Pages: 289 - 296

7. The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity

   • Eugene H. Herman
   • Jun Zhang
   • Victor J. Ferrans

   Original Article Pages: 297 - 304

8. Changes in the expression and binding properties of the estrogen receptor in MCF-7 breast cancer cells during growth inhibition by tamoxifen and cisplatin

   • Angela M. Otto
   • Sybilla Schubert
   • Roland Netzker

   Original Article Pages: 305 - 311

9. Co-amplification of dhfr and a homologue of hmsh3 in a Chinese hamster methotrexate-resistant cell line correlates with resistance to a range of chemotherapeutic drugs

   • Bhaswati Pandit
   • Madhumita Roy
   • Nitai P. Bhattacharyya

   Original Article Pages: 312 - 318

10. Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts

    • Robert A. Newman
    • Jun Yang
    • Nora M. Navone

    Original Article Pages: 319 - 326

11. Etoposide induction of tumor immunity in Lewis lung cancer

    • Lewis M. Slater
    • Marie Stupecky
    • Edward R. Arquilla

    Original Article Pages: 327 - 332

12. Influence of the interval between the administration of doxorubicin and paclitaxel on the pharmacokinetics of these drugs in patients with locally advanced breast cancer

    • António Moreira
    • Rosário Lobato
    • José Passos-Coelho

    Clinical Trial Report Pages: 333 - 337